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Background:  Cardiovascular  disease  is  the leading  cause  of  death  among  patients  with  chronic  kidney
disease  (CKD).  Therefore,  stratiﬁcation  of  the  prognostic  risk  of cardiovascular  events  is  useful  for  their
clinical  management.  We  evaluated  the  ability  of  electrocardiogram  (ECG)-gated  myocardial  perfusion
single photon  emission  computed  tomography  (SPECT)  to  predict  cardiac  events  among  Japanese  patients
at all  stages  of CKD  including  those  on hemodialysis.
Methods:  Patients  with  CKD undergoing  ECG-gated  myocardial  perfusion  SPECT  to  investigate  suspected
ischemic  heart  disease  were  followed  up to  monitor  retrospectively  major  cardiac  events  including  car-
diac death,  non-fatal  myocardial  infarction,  and  unstable  angina  pectoris.  Summed  stress  score,  summed
rest  score,  and summed  difference  score  were  estimated  with  a  20  segment  5-point  scoring  model.  The
severity  of  CKD  was  divided  into  ﬁve  levels  based  on  estimated  glomerular  ﬁltration  rate  (eGFR)  revised
for the Japanese  population.
Results:  The  follow-up  period  was  25.8 ±  11.0  months.  Sixty-two  major  cardiac  events  (cardiac  death,
n = 30;  non-fatal  myocardial  infarction,  n = 13; unstable  angina  pectoris,  n  = 19) developed  in 2243  patients
during  the  ﬁrst year  of follow-up.  The  ﬁndings  of  multivariate  Cox  proportional  hazards  regression  analy-
sis indicated  that  diabetes,  eGFR,  the  summed  difference  score,  and  summed  stress  score  were  signiﬁcant
independent  predictors  of cardiac  events.  The  major  cardiac  event  rate  at one year  increased  in propor-
tion  to the  progression  of  CKD  stage.  The  major  cardiac  event-free  survival  rate  decreased  steeply  over
time in  patients  with  CKD  stage  5  compared  with  those  who  had  CKD  stages  4  or less.
Conclusion:  Myocardial  perfusion  SPECT  can  contribute  to  the  prediction  of  cardiac  events  and  survival
in patients  at  all  stages  of  CKD  including  those  on  hemodialysis.
© 2012  Japanese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.ntroduction
Cardiovascular disease signiﬁcantly affects the prognosis of
atients with chronic kidney disease (CKD). Many patients with
KD die of cardiovascular events before starting hemodialysis ther-
py [1].  Recent ﬁndings have demonstrated that the incidence
f all death and cardiovascular events increase inversely with
stimated glomerular ﬁltration rate (eGFR). Go et al. [2] exam-
ned the multivariable association between the eGFR and the
isk of death, cardiovascular events, and hospitalization among
∗ Corresponding author at: Department of Cardiology, Nihon University School of
edicine, 30-1 Oyaguchi-Kamicho, Itabashi-Ku, Tokyo 173-8610, Japan.
el.: +81 3 3972 8111; fax: +81 3 3972 1098.
E-mail address: masteryoda@mf.point.ne.jp (S. Yoda).
914-5087/$ – see front matter © 2012 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2012.06.0111,120,295 adults registered in a large integrated healthcare sys-
tem. At least one outpatient determination of serum creatinine
levels was recorded for each registrant in a health-plan labora-
tory database, and they had not undergone dialysis or kidney
transplantation before entry. The results of the data analyses
showed that the risk of death and the hazard ratio for cardiovas-
cular events increased inversely with eGFR. The adjusted risk of
hospitalization also increased with a reduction in eGFR. Hakeem
et al. [3] reported that the incidence of cardiac death, all-cause
mortality, and non-fatal myocardial infarction (MI) was higher
in patients with CKD (eGFR < 60 mL/min/1.73 m2) than without
(eGFR > 60 mL/min/1.73 m2) who had known or suspected cardio-
vascular disease. They used stress myocardial perfusion single
photon emission computed tomography (SPECT) to predict adverse
cardiovascular events in these patients, and emphasized the prog-
nostic value of myocardial perfusion SPECT among patients with
vier Ltd. All rights reserved.
3 Cardio
C
i
u
t
d
r
a
t
S
o
o
J
y
a
v
k
c
r
c
s
m
v
e
t
m
f
i
T
a
h
d
p
l
M
p
e
A
i
P
c
s
t
N
M
d
t
d
f
(
d
p
t
u
p
h
e
a78 S. Yoda et al. / Journal of 
KD. In addition, because CKD patients have a risk of contrast-
nduced nephropathy, myocardial perfusion SPECT is considered
seful for screening coronary artery disease among such popula-
ions.
Recently, some large-scale prognostic studies using myocar-
ial perfusion SPECT were conducted in Japan, and the study
eports and the sub-analysis reports have been published one after
nother [4–9]. Nishimura et al. have been conducting the multicen-
er prospective Japanese Assessment of Cardiac Events and Survival
tudy (J-ACCESS), since 2001 to evaluate the prognostic value
f stress myocardial perfusion SPECT in patients with suspected
r conﬁrmed ischemic heart diseases. An interim report of the
-ACCESS [4] described the prognostic data obtained from a three-
ear follow-up of 4031 patients. Matsumoto et al. [5] conducted
 single-center prospective study to demonstrate the prognostic
alue of myocardial perfusion SPECT in 1846 Japanese patients with
nown or suspected coronary artery disease. Ohtaki et al. [6] also
onducted a single-center study in 4650 consecutive patients to
eport a risk of severe coronary artery disease in patients indi-
ating ischemic ST-segment changes with SPECT. Although these
tudies were typical Japanese large-scale prognostic studies with
yocardial perfusion SPECT, they did not examine the prognostic
alue of myocardial perfusion SPECT in patients with CKD. Hatta
t al. [7] extracted data regarding 820 patients with CKD from
he J-ACCESS database to determine the prognostic value of the
yocardial perfusion SPECT for cardiac events and survival. They
ound that the summed stress score derived from the SPECT image
s a reliable predictor of cardiac events among patients with CKD.
he J-ACCESS database, however, does not include information
bout patients with advanced renal dysfunction such as those on
emodialysis.
Therefore, we investigated whether or not ECG-gated myocar-
ial perfusion SPECT could predict cardiac events among Japanese
atients at all stages of CKD including those on hemodialysis in a
arge-scale follow-up study comparable to J-ACCESS.
aterials and methods
The institutional review board of Nihon University Itabashi Hos-
ital approved this study, which proceeded in accordance with the
thical standards established in the 1964 Declaration of Helsinki.
ll study participants provided written informed consent prior to
nclusion in this study.
atient population
We retrospectively investigated data obtained from 2967
onsecutive patients with CKD who underwent rest 201Tl and
tress 99mTc-tetrofosmin myocardial perfusion SPECT [5,10,11]
o conﬁrm or rule out suspected ischemic heart diseases at
ihon University Itabashi Hospital between October 2004 and
arch 2008. We  excluded patients aged ≤ 20 years, those who
eveloped acute MI  or unstable angina pectoris (UAP) within
hree months prior to the SPECT, those with hypertrophic or
ilated cardiomyopathy, serious valvular heart disease, heart
ailure with class III or higher New York Heart Association
NYHA) functional classiﬁcation, and those without creatinine
ata. Follow-up examinations were based on medical records for
atients who periodically attended the hospital and responses
o a posted questionnaire for patients who did not. The follow-
p was complete for 2611 (88%) of patients. Of these, 368
atients were excluded from prognostic analyses because they
ad undergone revascularization within 90 days of the SPECT
xamination. Data from the remaining 2243 patients were ﬁnally
nalyzed.logy 60 (2012) 377–382
Evaluation of eGFR
The GFR was  calculated from serum creatinine levels at the time
of SPECT for each patient in the ﬁnal prognostic analysis popula-
tion using the Modiﬁcation of Diet in Renal Disease Equation for
Japanese Patients proposed by the Japanese Society of Nephrology
[12] as follows:
eGFR = A × 194 × (serum creatinine)−1.094 × (age)−0.287,
where A is 1 for men  and 0.739 for women  and eGFR is expressed
as mL/min/1.73 m2.
ECG-gated dual-isotope myocardial perfusion SPECT
The procedure of rest 201Tl and stress 99mTc-tetrofosmin ECG-
gated myocardial perfusion SPECT was  performed as a protocol
previously reported [5,10,11]. All patients received an intravenous
(i.v.) injection of 201Tl (111 MBq) and sixteen-frame gated SPECT
image was  initiated 10 min  after injection during rest. Then an
i.v. injection of 99mTc-tetrofosmin (740 MBq) was performed under
stress induced by ergometer exercise in 31.5% of the patients or by
adenosine triphosphate in 68.5%. Sixteen-frame gated SPECT image
was initiated 30 min  after exercise or 30–60 min  after adenosine
stress. No attenuation or scatter correction was used. Twelve-lead
ECG was  monitored continuously during stress tests. Heart rate and
blood pressure were recorded at baseline and every minute for at
least 3 min  after stress.
SPECT image interpretation
The SPECT images were divided into 20 segments on three short-
axis (distal, mid, basal) and one vertical long-axis (mid) slices, and
the tracer uptake of each segment was visually scored using a
5-point scale (normal, slight, moderate, and severe reduction of
uptake, 0, 1, 2 and 3, respectively; absent uptake, 4). The sum total of
the scores of 20 segments in the stress and rest images provided the
summed stress score (SSS) and the summed rest score (SRS), respec-
tively. The summed difference score (SDS) was calculated as the
difference between the SSS and SRS. The severity of myocardial per-
fusion defects was classiﬁed as normal (SSS < 4), mildly (SSS 4–8),
moderately (SSS 9–13), and severely (SSS ≥ 14) abnormal. Cohen’s
kappa (), which was  calculated to determine the interobserver
variability for the perfusion score, was 0.92, indicating very good
reproducibility.
Sixteen-frame quantitative gated SPECT data were analyzed
using QGSTM software (Cedars-Sinai Medical Center, Los Angeles,
CA, USA) to calculate left ventricular ejection fraction (LVEF, %), end-
diastolic volume (LVEDV, mL)  and end-systolic volume (LVESV, mL)
as described by Germano et al. [13].
Patient follow-up
All patients were retrospectively followed up for at least one
year (25.8 ± 11.0 months) after the initial stress myocardial per-
fusion gated SPECT. The study endpoints comprised major cardiac
events within one year including cardiac death, non-fatal MI,  and
UAP identiﬁed from medical records or from responses to a posted
questionnaire. When a patient had several cardiac events, only the
ﬁrst event was taken as the follow-up endpoint.CKD staging
We  deﬁned CKD as stages 1–5 according to eGFR ranges of ≥90,
60–90, 30–59, 15–29, and <15 mL/min/1.73 m2, respectively.
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Table  1
Characteristics of patients with and without major cardiac events.
Cardiac event (+)
N  = 62
Cardiac event (−)
N = 2181
p-Value
Male sex 47 75.8% 1368 62.7% 0.0487
Age,  years 69 ± 10 68 ± 10 0.6796
Typical chest pain 15 24.2% 159 7.3% <0.0001
History of MI 25 40.3% 465 21.3% 0.0006
History of revascularization 26 41.9% 666 30.5% 0.0616
Hypertension 44 71.0% 1486 68.1% 0.7382
Diabetes mellitus 28 45.2% 629 28.8% 0.0082
Hyperlipidemia 18 29.0% 843 38.7% 0.1605
Smoking 21 33.9% 553 25.4% 0.1714
SSS  13.1 ± 8.8 4.9 ± 8.8 <0.0001
SRS  9.6 ± 7.3 3.0 ± 7.3 <0.0001
SDS  6.1 ± 4.0 1.9 ± 4.0 <0.0001
Rest  LVEF 51.1 ± 14.7 63.1 ± 14.7 <0.0001
Rest  LVEDV 106.5 ± 40.3 78.2 ± 40.3 <0.0001
Rest  LVESV 61.5 ± 33.8 32.9 ± 33.8 <0.0001
Stress  LVEF 50.0 ± 15.1 62.7 ± 15.1 <0.0001
Stress  LVEDV 123.8 ± 44.0 89.8 ± 44.0 <0.0001
Stress  LVESV 72.2 ± 38.3 38.4 ± 38.3 <0.0001
eGFR  47.7 ± 29.7 65.5 ± 27.0 <0.0001
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sI,  myocardial infarction; SSS, summed stress score; SRS, summed rest score; SDS, 
nd-diastolic volume; LVESV, left ventricular end-systolic volume; eGFR, estimated
tatistical analysis
Continuous variables were calculated as means and standard
eviations. Intergroup comparisons of continuous and categori-
al variables were achieved using an unpaired t test and the 2
est, respectively. Univariate analyses proceeded using a Cox pro-
ortional hazards model. Multivariate analyses proceeded using
 stepwise Cox proportional hazards model. A 2 for trend test
as used for detection of a steady proportion of outcomes to cat-
gorized interval-independent variables. All data were analyzed
sing MedCalc Software Version 10.3.0.0 (Mariakerke, Belgium). A
-value of <0.05 was considered statistically signiﬁcant.
esults
ardiac event rates and clinical characteristics of patients
Sixty-two major cardiac events (cardiac death, n = 30; non-fatal
I,  n = 13; UAP, n = 19) developed in 2243 patients with CKD during
he ﬁrst year of follow-up. Table 1 summarizes the characteris-
ics of the patients with and without major cardiac events. The
atios (%) of male to female patients and of patients who devel-
ped typical chest pain were signiﬁcantly higher (p = 0.0487 and
 < 0.0001, respectively), in the group with, than without major
ardiac events. Diabetes mellitus and a history of MI  were sig-
iﬁcantly more prevalent in the group with, than without major
ardiac events (p = 0.0006 and p = 0.0082, respectively). However,
he ratios of patients with a history of revascularization, hyperten-
ion, hyperlipidemia, or smoking habit were similar between the
wo groups. Myocardial defect scores (SSS, SRS, and SDS) as well as
VEDV and LVESV among QGS parameters in both rest and stress
mages were signiﬁcantly higher in the group with, than without
ajor cardiac events (both p < 0.0001). In contrast, LVEF in both
est and stress images and the eGFR were signiﬁcantly lower in the
roup with major cardiac events (both p < 0.0001).
elationship between SSS and major cardiac event ratesThe patients were classiﬁed according to SSS grades of nor-
al  (n = 1455), mildly (n = 281), moderately (n = 136), and severely
n = 371) abnormal to evaluate rates of major cardiac events and
urvival. The respective incidences of cardiac death at one year wereed difference score; LVEF, left ventricular ejection fraction; LVEDV, left ventricular
erular ﬁltration rate.
0.5%, 1.0%, 1.4%, and 4.4%. The cardiac death rate was signiﬁcantly
higher in the group classiﬁed as severely abnormal than in those
classiﬁed as normal (p < 0.0001) and mildly abnormal (p = 0.0022).
The respective incidences of major cardiac events at one year
were 1.0%, 3.9%, 5.9%, and 7.3% for normal, mildly, moderately,
and severely abnormal groups, respectively. The major cardiac
event rates increased in proportion to SSS severity and was signif-
icantly higher in the mildly (p = 0.0011), moderately (p < 0.0001),
and severely (p < 0 .0001) abnormal groups than in the normal
group. Typical stress/rest SPECT myocardial perfusion images in
patients with cardiac death and without any major cardiac events
are shown in Fig. 1.
Prediction of cardiac events
Table 2 shows the results of univariate Cox proportional hazards
regression analysis with major cardiac event rates as the depen-
dent variable. Signiﬁcant variables associated with increased major
cardiac event rates were age, male sex, typical chest pain, history
of MI,  history of revascularization, hypertension, diabetes melli-
tus, hyperlipidemia, summed defect scores (SSS, SRS, SDS), LVEF,
LVEDV, and LVESV in the rest and stress images, and eGFR.
The multivariate Cox proportional hazards regression model
analysis indicated diabetes mellitus (p = 0.0368), eGFR (p = 0.0001),
SSS (p < 0.0001), and SDS (p = 0.0009) as signiﬁcant independent
variables (Table 3).
Association between CKD and major cardiac event rates
Fig. 2 shows the major cardiac event rates during one year
among the patients with CKD. The rates of major cardiac event at
one year increased in proportion to the progression of CKD stage.
The major cardiac event rates were signiﬁcantly higher in patients
with CKD stages 4 (n = 67) or 5 (n = 102) than in those with CKD
stages 1 (n = 317; p < 0.01) or 2 (n = 983; p < 0.01). Furthermore, the
rates of major cardiac events in the patients with CKD stage 5
were signiﬁcantly higher than in those with CKD stage 3 (n = 774;
p < 0.01). The patients with CKD stage 5 included 82 (80.4%) who
were undergoing hemodialysis.
Fig. 3 shows the major cardiac event rates at one year according
to SSS values of <4 and ≥4 among patients with or without diabetes
mellitus and/or CKD stages 3 or higher. The major cardiac event
380 S. Yoda et al. / Journal of Cardiology 60 (2012) 377–382
Fig. 1. Typical stress/rest single photon emission computed tomography myocardial perfusion images in patients with cardiac death (A) and without any major cardiac
events (B). (A) The image was obtained from a 77-year-old male patient having hypertension, diabetes mellitus, history of myocardial infarction, and estimated glomerular
ﬁltration rate (eGFR) = 24.8 mL/min/1.73 m2, who  died of cardiac events. Hypoperfusion was observed in septal, apex, and inferior segments; the summed stress score (SSS)
was  19, the summed rest score (SRS) was 17, and the summed difference score was  2. (B) The image was  obtained from a 79-year-old male patient having hypertension and
eGFR  = 33.8 mL/min/1.73 m2, who  did not experience any major cardiac events. It indicated normal perfusion with SSS = 0, SRS = 0, and SDS = 0.
Table  2
Univariate Cox proportional hazards regression analysis.
Chi-square Hazard ratio 95% conﬁdence interval p-Value
Age 4.065 1.0194 1.0002–1.0389 0.0438
Male  sex 13.261 2.1644 1.3922–3.3650 0.0003
Typical chest pain 13.593 2.7022 1.6856–4.3319 0.0002
Ischemic ECG 1.324 1.3244 0.8341–2.1031 0.2499
History of MI  26.969 2.7688 1.9181–3.9969 <0.0001
History of revascularization 14.210 2.0439 1.4201–2.9418 0.0002
Hypertension 3.896 1.5210 0.9904–2.3359 0.0484
Diabetes mellitus 19.005 2.3076 1.5999–3.3282 <0.0001
Hyperlipidemia 4.781 0.6551 0.4460–0.9623 0.0288
Smoking 0.678 1.1843 0.7969–1.7598 0.4104
Family history 0.202 1.2677 0.4692–3.4253 0.6533
SSS  51.917 1.0583 1.0440–1.0727 <0.0001
SRS 21.218 1.0442 1.0277–1.0611 <0.0001
SDS  49.902 1.1179 1.0894–1.1471 <0.0001
Rest  LVEF 46.647 0.9635 0.9542–0.9730 <0.0001
Rest  LVEDV 28.070 1.0088 1.0061–1.0114 <0.0001
Rest  LVESV 32.045 1.0102 1.0074–1.0130 <0.0001
Stress  LVEF 57.989 0.9597 0.9502–0.9692 <0.0001
Stress  LVEDV 35.672 1.0089 1.0065–1.0113 <0.0001
Stress  LVESV 39.879 1.0101 1.0076–1.0127 <0.0001
eGFR  33.821 0.9780 0.9707–0.9852 <0.0001
ECG, electrocardiogram; MI,  myocardial infarction; SSS, summed stress score; SRS, summed rest score; SDS, summed difference score; LVEF, left ventricular ejection fraction;
LVEDV,  left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; eGFR, estimated glomerular ﬁltration rate.
Fig. 2. Incidence of major cardiac events at one year classiﬁed according to chronic
kidney disease (CKD) stages. Stages 1, 2, 3, 4, and 5 of CKD were taken as estimated
glomerular ﬁltration rate ≥90, 60–90, 30–59, 15–29, and <15 mL/min/1.73 m2,
respectively. Patients with CKD stages 4 or 5 and those with stages 1 or 2 signiﬁcantly
differed. Incidence of major cardiac events was signiﬁcantly higher in patients with
CKD stage 5 than stage 3.
Fig. 3. Incidence of major cardiac events at one year stratiﬁed according to summed
stress scores (SSS) in patients with or without chronic kidney disease (CKD) and/or
diabetes mellitus (DM). Incidence of major cardiac events signiﬁcantly differed
between patients with SSS ≥ 4 and <4 in all combinations.
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Table  3
Multivariate Cox proportional hazards regression analysis.
Hazard ratio 95% conﬁdence interval p-Value
Diabetes mellitus 1.5080 1.0276–2.2132 0.0368
eGFR 0.9831 0.9755–0.9908 <0.0001
SSS 1.0384 1.0204–1.0567 <0.0001
SDS  1.0548 1.0222–1.0884 0.0009
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Fig. 5. Incidence of major cardiac events at one year stratiﬁed according to summedGFR, estimated glomerular ﬁltration rate; SSS, summed stress score; SDS, summed
ifference score.
ates were signiﬁcantly higher in the subgroups with SSS ≥ 4 than
4 in all four populations: the patients with both diseases, those
ith only diabetes mellitus, those with only CKD, and those without
oth diseases.
Fig. 4 shows the major cardiac event rates at one year according
o SSS values of <4 and ≥4 among the patients with CKD. There were
igniﬁcant differences in the major cardiac event rates between
wo sub-groups with SSS < 4 and ≥4 among the patients with CKD
tages 2 and 3. Although the major cardiac event rates were not
igniﬁcantly different between two sub-groups with SSS < 4 and ≥4
mong the patients with CKD stages 1, 4, and 5, the results from chi-
quare for trend test indicated that the global rates are signiﬁcantly
igher in the sub-group with SSS ≥ 4 than <4.
Fig. 5 shows the rates of major cardiac event at one year strat-
ﬁed according to SSS values of <4 and ≥4 among patients with
GFR ≥ 60, 40–59, and <39. The rates of major cardiac events in the
roup with eGFR ≥60 were 0.8% and 4.9% in the patients with SSS < 4
n = 1056) and ≥4 (n = 246), respectively. The rates in the group
ith eGFR 40–59 were 1.7% (n = 481) and 6.7% (n = 178), respec-
ively, and 5.0% (n = 199) and 13.2% (n = 83), respectively, in the
roup with eGFR < 39. The major cardiac event rates increased with
ecreases in eGFR and the event rates were signiﬁcantly higher
mong patients with SSS ≥ 4 than <4 at every stage of CKD severity.
iscussion
This retrospective large-scale prognostic study assessed the
bility of ECG-gated myocardial perfusion SPECT to predict cardiac
eath, non-fatal MI,  and UAP in 2243 Japanese patients with CKD
uring a one-year follow-up. This study was considerably larger
han typical Japanese prospective studies [5,6], and it provided
aluable information about the prediction of cardiac event rates
n patients with severe CKD including those on hemodialysis. The
ig. 4. Incidence of major cardiac events at one year stratiﬁed according to summed
tress scores (SSS) in patients at each stage of chronic kidney disease (CKD). Stages
,  2, 3, 4 and 5 of CKD were taken as estimated glomerular ﬁltration rate ≥90, 60–90,
0–59, 15– 29, and <15 mL/min/1.73 m2, respectively. The major cardiac event rates
ere signiﬁcantly different between two sub-groups with SSS < 4 and ≥4 among the
atients with CKD stages 2 and 3.stress scores (SSS) in patients with renal function based on estimated glomerular ﬁl-
tration rates (eGFR). Incidence of major cardiac events signiﬁcantly differed between
patients with SSS ≥ 4 and <4 at all levels of renal function.
cardiac event rates at one year increased in proportion to progres-
sive CKD stage and the SSS obtained at a cut-off value of 4 from
nuclear cardiology allowed the prediction and risk stratiﬁcation of
cardiac events among patients at all stages of CKD.
European and American scientiﬁc articles describe that ECG-
gated myocardial perfusion SPECT can predict cardiac events in
patients with coronary artery diseases [14–16]. The guidelines
produced from a joint collaboration among the American College
of Cardiology, the American Heart Association, and the Ameri-
can Society of Nuclear Cardiology, recognize the value of cardiac
radionuclide imaging for diagnosis, judging disease severity, risk
assessment and prognosis of patients with acute and chronic
ischemic syndromes and heart failure, and recommend using ECG-
gated myocardial perfusion SPECT for prognostic evaluations of
patients with coronary artery diseases [17]. The ﬁndings of J-
ACCESS by Quantitative Gated SPECT also demonstrated the value
of ECG-gated myocardial perfusion SPECT for assessing Japanese
patients with suspected or conﬁrmed ischemic heart disease [4].
Hatta et al. [7] performed a sub-analysis of the J-ACCESS
database to identify useful predictors of cardiac events in patients
with CKD. Although their results demonstrated an incremental
value of ECG-gated myocardial perfusion SPECT for predicting car-
diac events in patients with CKD, the database did not include
patients with end-stage renal disease requiring hemodialysis.
Dahan et al. [18] reported that combined dipyridamole-exercise
thallium imaging is useful for detecting coronary stenosis and
for predicting cardiac events in patients undergoing hemodialy-
sis. Hase et al. [19] performed gated myocardial perfusion SPECT in
patients with end-stage renal disease within one month of start-
ing hemodialysis to predict cardiac events. They found that the
one-year cardiac event-free survival rate was signiﬁcantly lower
among patients with, than without perfusion defects (34% vs. 96%).
However, the prognostic value of ECG-gated myocardial perfusion
SPECT remained unknown for patients at all stages including those
undergoing hemodialysis and those at the conservative phase of
CKD. The present prognostic study, which was as large as J-ACCESS,
demonstrated that ECG-gated myocardial perfusion SPECT has
prognostic value for predicting cardiac events in Japanese patients
with any stage of CKD severity, including those on hemodialysis.
The present results were consistent with previous ﬁndings, indi-
cating that the ischemic indexes obtained from gated myocardial
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erfusion SPECT are independent signiﬁcant predictors of cardiac
vents. Diabetes mellitus was also associated with a prognostic risk,
nd combination of diabetes mellitus and CKD increased a risk of
ajor cardiac events. These results were similar to those reported
y the J-ACCESS groups [7,20,21]. Multivariate Cox proportional
azards regression analysis indicated that eGFR was  also a predic-
or of cardiac events. This evidence, which is consistent with the
esults of a J-ACCESS sub-study [7],  emphasizes that patients on
KD should be managed from the viewpoint of being at high risk
or cardiac events. In addition, the cardiac event rate increased as
he CKD stage progressed and was particularly high in patients with
tage 3 or higher. These results suggest the importance of early
anagement and risk stratiﬁcation before the CKD stage worsens.
ecognition is growing worldwide that CKD should be managed
t the early stages to prevent disease progression, reduce compli-
ations of a decreased GFR and risk of cardiovascular events, and
mprove survival and quality of life [22].
We assessed the prognostic risk stratiﬁcation of cardiac events
sing ECG-gated myocardial perfusion SPECT in patients at the con-
ervative phase of CKD. The cardiac event rate was  signiﬁcantly
igher in all patients in the group with SSS ≥ 4 and with mild
eGFR ≥ 60), moderate (eGFR 40–59), and severe (eGFR < 39) CKD
ompared with the group who had SSS < 4. These ﬁndings indicated
hat the summed defect scores obtained from nuclear cardiology
re useful for predicting cardiac events in patients at all stages of
KD.
The follow-up success rate in the present study was 88%,
hich is relatively lower than the >90% in other follow-up stud-
es [14,16,23] that used a scripted telephone interview to collect
ollow-up data. We  used a posted questionnaire rather than the
elephone, because written consent was required to collect med-
cal data from the patients. Despite the lower follow-up success
ate, the results of the present study are consistent with those of
revious reports, and also provide evidence that patients with CKD
tage 5 have a worse prognosis than patients with CKD stages 4 or
ess.
In conclusion, myocardial perfusion SPECT can contribute to the
rediction of cardiac events and survival in patients at all stages of
KD including those on hemodialysis.
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